PPD Launches Technology Portal to Improve Patient Retention in Clinical Trials
PPD, Inc. announced it has launched an online portal linking clinical trial participants with biopharmaceutical companies, physicians, and healthcare resources to enhance patient connectivity and improve retention in clinical trials.
PPD PatientView is a secure online technology empowering clinical trial participants to view, share, and electronically archive medical information related to their illness, enabling them to play a more active role in managing their health and actively engaging them throughout the duration of a clinical trial.
"Regulatory agencies are requiring longer, more complex clinical studies, increasing the likelihood of patients leaving a clinical study before it's completed," said Mike Wilkinson, executive vice president and chief information officer for PPD. "The loss of patients during a trial can lead to increased costs and delay the trial's completion. PPD PatientView empowers patients by enabling better communication with the study team, better connectivity with study activities and better access to information about their individual disease."
PPD PatientView is customizable, allows patients online access to valuable health information, and is a convenient way to stay in continual contact with the trial registry and monitoring program. The portal leverages Microsoft HealthVault, a personal health application platform that lets consumers gather, store and share health information online.
PPD PatientView is a part of PPD® Adaptive Solutions, the suite of integrated technology solutions that PPD deploys to meet each client's needs in advancing their research initiatives. PPD and Microsoft have announced plans to jointly implement a technology solution to improve efficiency in managing U.S. Food and Drug Administration-mandated Risk Evaluation and Mitigation Strategy (REMS) programs. PPD also was recognized on the 2010 InformationWeek 500, a list of the nation's most innovative users of business technology.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
